Skip to main content

Table 1 Patient characteristics

From: Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma

Characteristics

TACE

(n = 28)

TACE + MWA

(n = 23)

P value

Age

52 (34–65)

56 (36–69)

0.231b

Sex

  

0.842a

 Male

19 (68%)

15 (65%)

 

 Female

9 (32%)

8 (35%)

 

ECOG performance status

  

1.00c

 0

25 (89%)

21 (91%)

 

 1

3 (11%)

2 (9%)

 

Etiology

  

0.487c

 Hepatitis B

4 (14%)

1 (4%)

 

 Hepatitis C

16 (57%)

13 (57%)

 

 Alcohol

7 (25%)

6 (26%)

 

 Unknown

1 (4%)

3 (13%)

 

Child–Pugh class

  

0.802a

 A

18 (64%)

14 (61%)

 

 B

10 (36%)

9 (39%)

 

Vascular invasion

 Portal vein (2nd or 3rd order)

2 (7%)

1 (4%)

 

 Hepatic vein

0

0

 

AFP level

26.6 (2.9–655.2)

45.3 (4.2–876.7)

0.352

Tumor number

  

0.336c

 Single

16 (57%)

8 (35%)

 

 2

9 (32%)

10 (43%)

 

 3

3 (11%)

4 (17%)

 

  > 3

0

1 (5%)

 

Tumor diameter

  

0.254a

  < 3

9 (32%)

11 (48%)

 

 3⩾,< 5

19 (68%)

12 (32%)

 

Tumor location in liver

  

0.939a

 Right lobe

6 (21%)

4 (17%)

 

 Left lobe

12 (43%)

10 (43%)

 

 Both lobes

10 (36%)

9 (39%)

 
  1. The data correspond to number of events
  2. The data in parentheses correspond to percentages
  3. a Pearson chi-square test was used
  4. b Independent samples t test was used
  5. c Fisher exact test was used